Lupus Cerebritis as a Rare Neuropsychiatric Manifestation of Systemic Lupus Erythematosus
Open Access
- 13 May 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e24973
Abstract
Mixed connective tissue disease (MCTD) is a rare autoimmune condition that shows an overlap of at least two connective tissue diseases (CTD) including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), scleroderma, Sjögren’s syndrome, polymyositis, or dermatomyositis. From a laboratory standpoint, MCTD is associated with high titers of anti-U1-RNP antibodies, which makes it difficult to determine whether it is a variant of each of the respective CTDs or a different entity altogether. Our objective is to report the case of a patient with MCTD presenting with status epilepticus who was ultimately diagnosed with lupus cerebritis. The case also highlights the development of complications unrelated to MCTD that made the management even more challenging. Overall, the authors emphasize the rareness of lupus cerebritis as a presentation, the diagnostic challenges faced due to the lack of classical manifestations of SLE, and how the complicated clinical course makes a downhill prognosis more likely.Keywords
This publication has 6 references indexed in Scilit:
- Lupus Cerebritis as the Initial Presentation of Systemic Lupus Erythematosus in a Young FemaleCureus, 2021
- Clinical and Immunological Profile of Mixed Connective Tissue Disease and a Comparison of Four Diagnostic CriteriaInternational Journal of Rheumatology, 2020
- 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseasesModern Rheumatology, 2020
- Systemic lupus erythematosus: Diagnosis and clinical managementJournal of Autoimmunity, 2019
- Undifferentiated Connective Tissue Disease, Mixed Connective Tissue Disease, and Overlap Syndromes in Rheumatology.2016
- Neuropsychiatric Systemic Lupus ErythematosusCurrent Neuropharmacology, 2011